Biobeat

Petah Tikva, Israel · Founded 2014 · Privately Held (backing)

Developer of a wearable remote patient monitoring device designed to measure vital signs using wireless, non-invasive, and medical-grade technology. Biobeat is based in Petah Tikva, Israel and was founded in 2014. Its last reported valuation was $103 million in May 2024. It has raised $71.8 million.

Last reported valuation
$102.7M
Oct 2026
Priced at
—
Total raised
$71.8M
Last round
—
Cap table — not yet on record

Biobeat's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Biobeat with a free account
  • ·The complete investor list: 15 names
  • ·Watch Biobeat: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View